The Net Margin of Calliditas Therapeutics AB (CALTX.ST) is -38.63%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2023-12-31 | -38.63% |
| 2022-12-31 | -51.35% |
| 2021-12-31 | -218.14% |
| 2020-12-31 | -49598.86% |
| 2019-12-31 | -17.63% |